MedCity News September 12, 2019
Arno Sosna

As AR matures and becomes more affordable and user-friendly, more life sciences companies should consider its use as an essential tool to communicate, educate, and engage HCPs and patients on innovations that will improve outcomes.

More life sciences companies are using augmented reality (AR) to bring new therapies to life by combining virtual and physical worlds. AR helps create rich, interactive experiences that show how new drugs and medical devices interact with the body. Using this disruptive technology, brand teams and content providers can give their field force a better way to engage healthcare professionals (HCPs). AR can also allow HCPs to be more illustrative when explaining new treatments to patients.

Whether explaining a disease state, treatment method,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Metaverse/VR, Provider, Technology
Old Dominion University, HaptX, Georgia Tech receive grant for VR for the visually impaired
FDA initiative puts AR/VR at heart of home health drive
Meta's Reality Labs posts $3.85 billion loss in first quarter
Meta Aims to Ignite Enterprise Productivity With Open Metaverse OS
Mark Zuckerberg says Meta will offer its virtual reality OS to hardware companies, creating iPhone versus Android dynamic

Share This Article